TimeSessionPlay
09:00-10:00

Akutna srčana slabost: izazovi u našoj svakodnevnoj praksi / Acute heart failure: challenges in everyday practice
SINERGY & friends/SINERGIJA & Udruženje koronarnih jedinica Srbije

Zorana Vasiljević-Pokrajčić (Belgrade, RS), Milika Ašanin (Belgrade, RS), Marija Zdravković (Belgrade, RS), Predrag Mitrović (Belgrade, RS), Marija Polovina (Belgrade, RS), Goran Čolaković (Belgrade, RS)

Prva prezentacija akutne srčane slabosti kod mladog bolesnika/First presentation of acute heart failure in a young patient
Marija Polovina (Belgrade, RS)

Akutna srčana slabost: šta se krije iza troponina preko 20,000 ng/L/Acute heart failure: what hides behind a troponin level over 20.000 ng/L
Slobodan Klašnja (Belgrade, RS)

Akutna srčana slabost: zašto je etiologija važna?/Acute heart failure: importance of understanding the underlying mechanisms
Marija Zdravković (Belgrade, RS)

10:00-11:00

Šta je novo u kardiologiji: velike studije sa kongresa ESC 2022 / What is new in cardiology: late breaking trials from the ESC 2022

Goran Stanković (Belgrade, RS), Tatjana Potpara (Belgrade, RS), Arsen Ristić (Belgrade, RS)

Koncept i ciljevi sesije / Session rationale and concept
Goran Stanković (Belgrade, RS)

PCI kod bolesnika sa ishemijskom kardiomiopatijom / REVIVED trial (Percutaneous Revascularisation for Ischaemic Ventricular Dysfunction)
Goran Stanković (Belgrade, RS)


Dapagliflozin kod bolesnika srčanom slabošću i očuvanom ejekcionom frakcijom leve komore / DELIVER trial (Dapagliflozin in Heart Failure with Mildly Reduced and Preserved Ejection Fraction)
Arsen Ristić (Belgrade, RS)

Novi dokazi na polju lečenja srčanih aritmija / Evidence base update in arrhythmias 
Tatjana Potpara (Belgrade, RS)

10.45-12.00

EBC konsenzus iz 2022. godine: zamke u perkutanom lečenju koronarnih bifurkacija - prvi deo / EBC Consensus 2022 – pitfalls in bifurcation PCI - part 1

Goran Stanković (Belgrade, RS), Remo Albiero (Rome, IT),Yves Louvard (Paris, FR), Jens Flensted Lassen (Odense, DK), Francesco Burzotta (Rome, IT), Thomas Johnson (Bristol, UK)

Pitfalls of provisional strategy
Remo Albiero (Rome, IT)

Pitfalls of T-/TAP
Francesco Burzotta (Rome, IT)

Simulation based learning: Dejan Milašinović (Belgrade, RS), Zlatko Mehmedbegović (Belgrade, RS), Mila Kovačević (Novi Sad, RS)


A joint educational project between SINERGY and

12:00-12:15

Velika imena kardiologije / Meet the legends

Valentin Fuster (New York, USA)
Glavni urednik / Editor in Chief Journal of American College of Cardiology (JACC)
Direktor / Director of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital,
New York, USA
Generalni direktor / General Director of the National Centre for Cardiovascular Research
(CNIC), Madrid, Spain


Interviewers: Goran Stanković (Belgrade, RS), George Dangas (New York, US)

12:15-13:00

HoloLens virtuelno navođenje u Sali za kateterizaciju UŽIVO iz Arendala, Norveška / HoloLens proctoring in the cath lab LIVE from Arendal, Norway

A case of complex bifurcation PCI with HoloLens proctoring

Slobodan Ćalić (Arendal, NO), Christian Eek (Oslo, NO), Jahn Otto Næsgaard Andersen (Oslo, NO)
Valery Gelev (Sofia, BG), Dragan Debeljački (Novi Sad, RS), Tomislav Jakljević (Rijeka, HR), Saško Kedev (Skoplje, MK), Siniša Stojković (Belgrade, RS)

13.15-13.55

Svečano otvaranje  / Opening ceremony

Goran Stanković (Belgrade, RS), Milika Ašanin (Belgrade, RS), Lazar Davidović (Belgrade, RS)

Pozdravna reč / Welcome note
Pedstavnik Ministarstva zdravlja RS / Representative of Ministry of health RS
Milika Ašanin (Belgrade, RS)
Lazar Davidović (Belgrade, RS)
Goran Stanković (Belgrade, RS)

Dodela zvanja profesor po pozivu Medicinskog fakulteta Univerziteta u Beogradu profesoru Jens Flensted Lassen-u 
Visiting professor at Faculty of medicine University of Belgrade Jens Flensted Lassen

Najznačajnije randomizovane studije u kardiologiji u poslednjoj deceniji / Key note lecture: the most important RCTs in cardiology in the last decade

Jens Flensted Lassen (Odense, DK)

SINERGIJA znanja i prijateljstva / SINERGY of knowledge and friendship

Marko Noč (Ljubljana, SI)

14.00-15.15TBC
15.15-16.15

OCT & IVUS u svakodnevnoj praksi  / OCT & IVUS in everyday practice

Predsedavajući/Chairpersons: Salvatore Brugaletta (Barcelona, ES), Thomas Johnson (Bristol, UK)
Panelisti/Panelists:
Vladimir Ivanović (Novi Sad, RS), Milan Dobrić (Belgrade, RS), Zlatko Mehmedbegović (Belgrade, RS), Aleksandar Davidović (Belgrade, RS), Predrag Đuran (Belgrade, RS), Mladen Tasić (Belgrade, RS), Bojan Maričić (Niš, RS), Rada Vučić (Kragujevac, RS), Saša Dželebžić (Subotica, RS), Milenko Čanković (Novi Sad, RS), Dejan Milašinović (Belgrade, RS)

IVUS kod bolesnika sa stenozom glavnog stabla / IVUS in left main PCI
Salvatore Brugaletta (Barcelona, ES)

OCT kod bolesnika sa bifurkacionom stenozom / OCT in bifurcation PCI
Thomas Johnson (Bristol, UK)

OCT kod bolesnika sa akutnim koronarnim sindromom / OCT in patients with ACS
Milenko Čanković (Novi Sad, RS)

OCT kod bolesnika sa kalcifikovanom stenozom / OCT in patients with calcified lesions
Dejan Milašinović (Belgrade, RS)

16.15-17.00

Moderni pristup perkutanom lečenju kalcifikovane stenoze glavnog stabla / Modern PCI in calcific left main stenosis

Uvod/Introduction 

Jens Flensted Lassen (Odense, DK)


Prikaz slučaja i diskusija o strategiji/Case presentation and strategy discussion
Jens Flensted Lassen (Odense, DK)

Upotreba IVUS-a kod PCI glavnog stabla/IVUS guidance in LM PCI

Dejan Milašinović (Belgrade, RS)

Rešavanje slučaja i diskusija/Case resolution and discussion
Jens Flensted Lassen (Odense, DK)


Algoritam pristupa kalcifikovanim lezijama glavnog stabla/Calcium algorithm applied to calcific LM Stenosis

Istvan Ferenc Edes (Budapest, HU)

Zatvaranje/Closing
Jens Flensted Lassen (Odense, DK)

Sponsored by Boston Scientific

17.00-18.00Dijabetes i lipidi: šta kardiolog treba da zna u 2022. godini? / Diabetes and lipids: what should cardiologist know in 2022

Nebojša Lalić (Belgrade, RS), Katarina Lalić (Belgrade, RS), Aleksandra Jotić (Belgrade, RS)

Šta znamo o gestacijskom dijabetesu kao faktoru rizika za kardiovaskularnu bolest?/What do we know about gestational diabetes as a risk factor for cardiovascular disease?
Aleksandra Jotić (Belgrade, RS)

Savremene preporuke za lečenje hiperglikemije u tipu 2 dijabetesa: kako postići kardioprotektivnost?/ Updates of the recomendations for the treatment of hyperglycemia in type 2 diabetes: how to achieve cardioprotective effect?
Nebojša Lalić (Belgrade, RS)

Novi pristupi prevenciji kardiovaskularne bolesti u terapiji dislipidemija/ New approaches to the prevention of cardiovascular disease in the treatment of dyslipidemias
Katarina Lalić (Belgrade, RS)

18.00-19.00

Velika imena o velikim temama kardiologije – intervjui sa povodom / Meet the legends: what is hot today  in the treatment of cardiovascular diseases?

Patrick W. Serruys (Galway, IE), Antonio Colombo (Milano, IT), Gregory Y. H. Lip (Liverpool, UK)
Interviewers: Goran Stanković (Belgrade, RS), Tatjana Potpara (Belgrade, RS), Dejan Milašinović (Belgrade, RS)

In 2022 and beyond, routine stenting may not be the default approach to PCI / Da li je budućnost perkutanih koronarnih intervencija bez stenta?
Antonio Colombo (Milano, IT)

PCI or CABG: the enduring legacy of SYNTAX / PCI ili bajpas hirurgija: trajne pouke SYNTAX studijskog programa
Patrick W. Serruys (Galway, IE)

CHA 2 DS 2 -VASc score: past, present and future / CHA 2 DS 2 -VASc skor: prošlost, sadašnjost i budućnost
Gregory Y. H. Lip (Liverpool, UK)